These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2299641)

  • 1. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
    Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
    J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
    Xiong WC; Nelson DL
    Life Sci; 1989; 45(16):1433-42. PubMed ID: 2811600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.
    Leonhardt S; Herrick-Davis K; Titeler M
    J Neurochem; 1989 Aug; 53(2):465-71. PubMed ID: 2664084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
    Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ; Peroutka SJ
    J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
    Glennon RA; Chaurasia C; Titeler M
    J Med Chem; 1990 Oct; 33(10):2777-84. PubMed ID: 2213830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
    Heuring RE; Peroutka SJ
    J Neurosci; 1987 Mar; 7(3):894-903. PubMed ID: 2951504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
    Peroutka SJ
    J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.
    Nowak HP; Mahle CD; Yocca FD
    Br J Pharmacol; 1993 Aug; 109(4):1206-11. PubMed ID: 8401931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
    Tamir H; Liu KP; Hsiung SC; Yu PY; Kirchgessner AL; Gershon MD
    J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
    Zemlan FP; Schwab EF
    J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.